Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
An erratum to this article was published (Lancet Diabetes Endocrinol, Feb 2024 ↗)
Recommendations
As issued by the authors
Continuous glucose monitoring (CGM)-derived metrics, with standardised, internationally agreed reporting formats, should be considered for use in all clinical studies in diabetes
Recommendations on how to optimise CGM-derived glucose data collection in clinical studies, including the specific glucose metrics that should be evaluated
Original publication
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. Published 6 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →